Netflix Inc. (NFLX) Financials Nov 14, 2014, 7:58
Netflix Inc. (NFLX) Financials Nov 14, 2014, 7:58 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Netflix Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.67B 2.16B 3.2B 3.61B 4.37B
Cost of Goods Sold (COGS) incl. D&A 1.08B 1.36B 2.04B 2.63B 3.08B
COGS excluding D&A 821.74M 1.02B 1.2B 923.78M 841.58M
Depreciation & Amortization Expense 257.53M 338.7M 839.62M 1.7B 2.24B
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income 591M 805.27M 1.16B 983.42M 1.29B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 403.62M 527.72M 779.61M 933.42M 1.06B
Research & Development 114.54M 163.33M 259.03M 329.01M 378.77M
Other SG&A 289.08M 364.39M 520.58M 604.42M 684.19M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 9M 0 25.13M
EBIT after Unusual Expense 0 0 (9M) 0 (25.13M)
Non Operating Income/Expense 6.06M 8.09M 700,000 (4M) (8.4M)
Non-Operating Interest Income 5.23M 1.68M 2.78M 4.47M 5.4M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 6.48M 19.63M 20.03M 19.99M 29.14M
Gross Interest Expense 6.48M 19.63M 20.03M 19.99M 29.14M
Interest Capitalized 0 0 0 0 0
Pretax Income 192.19M 267.7M 359.52M 30.48M 171.07M
Income Tax 76.33M 106.84M 133.4M 13.33M 58.67M
Income Tax - Current Domestic 70M 107.79M 152.06M 42.24M 73.71M
Income Tax - Current Foreign - - (70,000) 1.16M 7M
Income Tax - Deferred Domestic 6.33M (949,000) (18.6M) (30.07M) (21.68M)
Income Tax - Deferred Foreign - - - - (363,000)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 115.86M 160.85M 226.13M 17.15M 112.4M
Minority Interest Expense 0 0 0 0 0
Net Income 115.86M 160.85M 226.13M 17.15M 112.4M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 115.86M 160.85M 226.13M 17.15M 112.4M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 115.86M 160.85M 226.13M 17.15M 112.4M
EPS (Basic) 2.05 3.06 4.28 0.31 1.93
Basic Shares Outstanding 56.56M 52.53M 52.85M 55.52M 58.2M
EPS (Diluted) 1.98 2.96 4.16 0.29 1.85
Diluted Shares Outstanding 58.42M 54.3M 54.37M 58.9M 60.76M
EBITDA 444.91M 616.24M 1.22B 1.75B 2.47B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Top 5 Most Recently Viewed Articles
Solar Insure Introduces a New Battery Warranty Solar Insure is making a significant stride in the renewable energy sector with the introduction of the SI-30 Battery Warranty. This new warranty, featuring an impressive 30-year protection plan, is designed to give homeowners and solar providers peace of mind regarding their energy storage solutions. As battery storage...
Continue Reading
Understanding Opendoor's Recent Settlement Opendoor Technologies (NASDAQ: OPEN) recently found itself in the spotlight due to a $39 million settlement aimed at resolving a federal class action lawsuit. This lawsuit stemmed from allegations that Opendoor misrepresented the effectiveness of its home-pricing algorithms, claiming to have improved automation when, in reality,...
Continue Reading
Scandinavian Tobacco Group Enhances Shareholder Value Scandinavian Tobacco Group A/S has recently taken significant steps to bolster its capital structure through a well-planned share buy-back program. This initiative aims to enhance shareholder value and support the management of obligations related to the company’s employee share-based incentive programs. Overview of...
Continue Reading
The Shift in Akebia Therapeutics' Approach Akebia Therapeutics Inc. (NASDAQ: AKBA) has made headlines recently as its stock experienced a decline in value. This downward trend coincided with important discussions held between the company and the U.S. Food and Drug Administration (FDA) regarding its pivotal trial design for vadadustat, intended to treat anemia in patients...
Continue Reading
Art Ave Launches Exciting Fall Activities In the bustling heart of downtown, a new wave of creativity is set to unfold. This fall, the Golden Triangle Business Improvement District (BID) is thrilled to present Art Ave, an exhilarating outdoor initiative designed to connect the White House and Dupont Circle through vibrant public art and enriched community engagement....
Continue Reading